Seoul, South Korea

Seong-Hyun Ho

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Seong-Hyun Ho: Innovator in Biopolymer and Gene Therapy

Introduction

Seong-Hyun Ho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of biopolymer technology and gene therapy. With a total of 3 patents, his work focuses on enhancing gene expression and developing innovative therapeutic solutions.

Latest Patents

One of his latest patents is a composition for increasing the expression of a growth factor gene, which comprises core-shell structured microparticles as an active ingredient. This composition can increase the expression of co-administered genes by at least 30%, particularly when used with genes such as the human hepatocyte growth factor (HGF) or the human insulin-like growth factor 1 (IGF1). Another notable patent involves biopolymer conjugates comprising an interleukin-11 analog. These conjugates demonstrate enhanced resistance to acidolysis and increased stability, offering a longer serum half-life and maintaining activity compared to unconjugated forms.

Career Highlights

Seong-Hyun Ho has worked with notable companies such as Viromed Co., Ltd. and Biopolymed Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the biotechnology sector.

Collaborations

He has collaborated with esteemed colleagues, including Jong-Mook Kim and Eun-Jin Park, contributing to the advancement of research and development in his field.

Conclusion

Seong-Hyun Ho's work exemplifies the intersection of innovation and practical application in biotechnology. His patents reflect a commitment to improving therapeutic outcomes through advanced biopolymer and gene therapy technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…